nach oben

Erschienen in:

2015 | OriginalPaper | Buchkapitel

5. Diagnostik und Therapie bei diabetisch-neuropathischer Osteoarthropathie

verfasst von : Priv.-Doz. Dr. med. S. Zimny, Dr. med. U. Waldecker, Prof. Dr. med. A. Eckardt

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die diabetische neuropathische Osteoarthropathie (DNOAP), im klinischen Alltag meist »Charcot-Fuß« genannt, stellt als nichtinfektiöse Zerstörung von Knochen und Gelenken im Zusammenhang mit der Neuropathie eine Sonderform des diabetischen Fuß-Syndroms dar. Die DNOAP ist eine chronische und progressiv verlaufende Erkrankung der Knochen und Gelenke, charakterisiert durch entweder schmerzhafte oder schmerzlose Destruktion, hautsächlich im Bereich des Fußes lokalisierter Knochen- und Gelenkstrukturen. Häufig wird diese Spätkomplikation des Diabetes mellitus zumindest in den Anfangsphasen verkannt und führt unsachgemäß behandelt zu einer progredienten Zerstörung des Fußskeletts und zur Invalidität der betroffenen Patienten. Im akuten Stadium ist eine komplette Druckentlastung des Fußes, im chronischen Stadium eine entsprechende Maßschuhversorgung oder ggf. eine operative Korrektur zur Vermeidung von Fußulzerationen anzustreben.

Armstrong DG, Lavery LA (1997) Monitoring healing of acuteCharcot's arthropathy with infrared dermal thermometry.J Rehabil Res Dev 34: 317–321

Armstrong DG, Lavery LA (1998) Acute Charcot's arthropathyof the foot and ankle. PhysTher 78: 74–80

Armstrong DG, Lavery LA (1998) Elevated peak plantar pressuresin patients who have Charcot arthropathy. J BoneJoint Surg Am 80: 365–369

Armstrong DG, Peters EJ (2002) Charcot's arthropathy of thefoot. J Am Podiatr Med Assoc 92: 390–394

Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR (1997) The natural history of acute Charcot's arthropathyin a diabetic foot specialty clinic. Diabet Med 14: 357–363CrossRef

Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR (1997) The natural history of acute Charcot's arthropathyin a diabetic foot specialty clinic. J Am Podiatr Med Assoc87: 272–278

Bayne O, Lu EJ (1998) Diabetic Charcot's arthropathy of thewrist. Case report and literature review. ClinOrthop 357:122–126

Becker W (1999) Imaging osteomyelitis and the diabetic foot.Q J Nucl Med 43: 9–20PubMed

Berg EE (1997) Charcot arthropathy after acetabular fracture.J Bone Joint Surg Br 79: 742–745CrossRef

Boc SF, Brazzo K, Lavian D, Landino T (2001) Acute Charcotfoot changes versus osteomyelitis: does Tc-99 m HMPAOlabeled leukocytes scan differentiate? J Am Podiatr MedAssoc 91: 365–368

Chantelau E, Richter A, Ghassem-Zadeh N, Poll LW (2007)≫Silent≪ bone stress injuries in the feet of diabeticpatients with polyneuropathy: a report on 12 cases. Arch Orthop Trauma Surg 127(3):171–7PubMedCrossRef

Childs M, Armstrong DG, Edelson GW (1998) Is Charcot arthropathya late sequela of osteoporosis in patients withdiabetes mellitus? J Foot Ankle Surg 37: 437–439CrossRef

Clohisy DR, Thompson RC (1988) Fractures associated withneuropathic arthropathy in adults who have juvenileonsetdiabeteS J Bone Joint Surg Am 70: 1192–1200

Cofield RH, Morrison MJ, Beabout JW (1983) Diabetic neuroarthropathyin the foot: patient characteristics and patternsof radiographic change. Foot Ankle 4: 15–22PubMedCrossRef

Connolly JF, Jacobsen FS (1985) Rapid bone destruction after astress fracture in a diabetic (Charcot) foot. Nebr Med J 70:438–440

Craig JG, Amin MB, Wu K et al. (1997) Osteomyelitis of thediabetic foot: MR imaging-pathologic correlation. Radiology 203: 849–855CrossRef

Deely DM, Schweitzer ME (1997) MR imaging of bone marrowdisorders. RadiolClin North Am 35: 193–212

Devendra D, Farmer K, Bruce G et al. (2001) Diagnosing osteomyelitisin patients with diabetic neuropathic osteoarthropathy. Diab Care 24: 2154–2155CrossRef

Edmonds ME (1999) Progress in care of the diabetic foot. Lancet 354: 270–272CrossRef

Edmonds ME, Roberts VC, Watkins PJ (1982) Blood flow in thediabetic neuropathic foot. Diabetologia 22: 9–15PubMedCrossRef

Eichenholtz SN (1966) Charcot Joints. Charles Thomas, SpringfieldEnderle MD, Coerper S, Schweizer HP et al. (1999) Correlationof imaging techniques to histopathology in patients withdiabetic foot syndrome and clinical suspicion of chronicosteomyelitiSThe role of high-resolution ultrasound. Diab Care 22: 294–299

Fabrin J, Larsen K, Holstein PE (2000) Long-term follow-up indiabetic Charcot feet with spontaneous onset. Diab Care23: 796–800

Foltz KD, Fallat LM, Schwartz S (2004) Usefulness of a brief assessmentbattery for early detection of Charcot foot deformityin patients with diabetes. J Foot Ankle Surg 43: 87–92PubMed

Frykberg RG, Kozak GP (1978) Neuropathic arthropathy in thediabetic foot. AmFam Physician 17: 105–113

Gazis A, Pound N, Macfarlane R et al. (2004) Mortality in patientswith diabetic neuropathic osteoarthropathy (Charcotfoot).Diabet Med 21: 1243–1246CrossRef

Gill G, Benbow S, Tesfaye S, Kaczmarczyk E, Kaye L (1997) Painless stress fractures in diabetic neuropathic feet. Postgrad Med J 73: 241–242PubMedCentral

Gold RH, Tong DJ, Crim JR, Seeger LL (1995) Imaging thediabetic foot. Skeletal Radiol 24: 563–571CrossRef

Gough A, Abraha H, Li F et al. (1997) Measurement of markersof osteoclast and osteoblast activity in patients withacute and chronic diabetic Charcot neuroarthropathy. Diabet Med 14: 527–531CrossRef

Grant WP, Sullivan R, Sonenshine DE et al. (1997) Electronmicroscopic investigation of the effects of diabetes mellituson the Achilles tendon. J Foot Ankle Surg 36: 272–278CrossRef

Griffith J, Davies AM, Close CF, Nattrass M (1995) Organizedchaos?Computed tomographic evaluation of the neuropathicdiabetic foot. Br J Radiol 68: 27–33PubMedCrossRef

Holmes GB, Hill N (1994) Fractures and dislocations of the footand ankle in diabetics associated with Charcot jointchanges. Foot Ankle Int 15: 182–185

Jude EB, Selby PL, Burgess J et al. (2001) Bisphosphonates inthe treatment of Charcot neuroarthropathy: a doubleblindrandomised controlled trial. Diabetologia 44:2032–2037CrossRef

Klenerman L (1996) The Charcot joint in diabetes. Diabet Med 13(Suppl 1): S52–S54

Knight D, Gray HW, McKillop JH, Bessent RG (1988) Imagingfor infection: caution required with the Charcot joint. Eur J Nucl Med 13: 523–526CrossRef

Lambert AP, Close CF (2002) Charcot neuroarthropathy of theknee in Type 1 diabetes: treatment with total kneearthroplasty. Diabet Med 19: 338–341

Larroque G, Kamba C, Blin D, Lopez FM, Cyteval C (2006) Imaging of the diabetic foot. J Radiol 87(5):541–7PubMedCrossRef

Larsen K, Fabrin J, Holstein PE (2001) Incidence and managementof ulcers in diabetic Charcot feet. J Wound Care 10:323–328CrossRef

Lipman BT, Collier BD, Carrera GF et al. (1998) Detection ofosteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. ClinNucl Med 23:77–82

Luetters CM, Keegan TH, Sidney S et al. (2004) Risk factors forfoot fracture among individuals aged 45 years and older. OsteoporosInt 12: 957–963

McEwen LN et al. (2013) Prevalence and risk factors for diabetes-related foot complications in Translating ResearchInto Action for Diabetes (TRIAD). J Diabetes Complications27(6): 588–92

Pakarinen TK, Laine HJ, Honkonen SE et al. (2002) Charcotarthropathy of the diabetic foot. Current concepts andreview of 36 cases. Scand J Surg 91: 195–201PubMed

Palestro CJ, Caprioli R, Love C et al. (2003) Rapid diagnosis ofpedal osteomyelitis in diabetics with a technetium-99mlabeledmonoclonal antigranulocyte antibody. J FootAnkle Surg 42: 2–8

Palestro CJ, Mehta HH, Patel M et al. (1998) Marrow versusinfection in the Charcot joint: indium-111 leukocyte andtechnetium-99 m sulfur colloid scintigraphy. J Nucl Med39: 346–350

Phillips S, Williams AL, Peters JR (1995) Neuropathic arthropathyof the spine in diabetes. Diab Care 18: 867–869CrossRef

Piaggesi A, Rizzo L, Golia et al. (2002) Biochemical and ultrasoundtests for early diagnosis of active neuro-osteoarthropathy(NOA) of the diabetic foot. Diabetes Res ClinPract 58: 1CrossRef

Pinzur MS, Shields N, Trepman E, Dawson P, Evans A (2000) Current practice patterns in the treatment of Charcotfoot. Foot Ankle Int 21: 916–920

Remedios D, Valabhji J, Oelbaum R, Sharp P, Mitchell R (1998) 99mTc-nanocolloid scintigraphy for assessing osteomyelitisin diabetic neuropathic feet. ClinRadiol 53: 120–125

Rubello D, Casara D, MaranA et al. (2004) Role of anti-granulocyteFab’ fragment antibody scintigraphy (LeukoScan) inevaluating bone infection: acquisition protocol, interpretationcriteria and clinical resultSNucl Med Commun 25:39–47

Sanders LJ (2004) The Charcot foot: historical perspective1827-2003. Diabetes Metab Res Rev 20 (Suppl 1): S4–S8CrossRef

Sanders LJ, Frykberg RG (1993) Charcot Foot. Mosby YearBook, St. Louis, pp 149–180

Seabold JE, Flickinger FW, Kao SC et al. (1990) Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonanceimaging: difficulty of diagnosing osteomyelitis inpatients with neuropathicosteoarthropathy. J Nucl Med31: 549–556

Sella EJ, Barrette C (1999) Staging of Charcot neuroarthropathyalong the medial column of the foot in the diabeticpatient. J Foot Ankle Surg 38: 34–40PubMedCrossRef

Shapiro SA, Stansberry KB, Hill MA et al. (1998) Normal bloodflow response and vasomotion in the diabetic Charcotfoot. J Diabetes Complic 12: 147–153CrossRef

Shaw JE, van Schie CH, Carrington AL, Abbott CA, Boulton AJ (1998) An analysis of dynamic forces transmitted throughthe foot in diabetic neuropathy. Diab Care 21: 1955–1959CrossRef

Sinha S, Munichoodappa CS, Kozak GP (1972) Neuro-arthropathy(Charcot joints) in diabetes mellitus (clinical studyof 101 cases). Medicine 51: 191–210PubMedCrossRef

Slowman-Kovacs SD, Braunstein EM, Brandt KD (1990) Rapidlyprogressive Charcot arthropathy following minor jointtrauma in patients with diabetic neuropathy. ArthritisRheum 33: 412–417CrossRef

Smith DG, Barnes BC, Sands AK, Boyko EJ, Ahroni JH (1997) Prevalence of radiographic foot abnormalities in patientswith diabetes. Foot Ankle Int 18: 342–346CrossRef

Sohn MW et al. (2009) Mortality risk of Charcot arthropathycompared with that of diabetic foot ulcer and diabetesalone. Diabetes Care 32(5): 816–21PubMedCrossRef

Stevens MJ, Edmonds ME, Foster AV, Watkins PJ (1992) Selectiveneuropathy and preserved vascular responses in thediabetic Charcot foot. Diabetologia 35: 148–154CrossRef

Thompson RC, Clohisy DR (1993) Deformity following fracturein diabetic neuropathic osteoarthropathy. Operativemanagement of adults who have type-I diabetes. J BoneJoint Surg Am 75: 1765–1773

Tomas MB, Patel M, Marwin SE, Palestro CJ (2000) The diabeticfoot. Br J Radiol 73: 443–450CrossRef

vanNetten JJ, Prijs M, van Baal JG, Liu C, van der Heijden F, Bus SA (2014) Diagnostic Values for Skin TemperatureAssessment to Detect Diabetes-Related Foot Complications.Diabetes Technology & Therapeutics. [Epub ahead of print]

Wilson M (1991) Charcot foot osteoarthropathy in diabetesmellitus. Mil Med 156: 563–569

Wolfe L, Stess RM, Graf PM (1991) Dynamic pressure analysisof the diabetic charcot foot. J Am Podiatr Med Assoc 81:281–287CrossRef

Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJ (1995) Osteopenia, neurological dysfunction, and the developmentof Charcot neuroarthropathy. Diab Care 18: 34–38

Armstrong DG, Lavery LA (1997) Monitoring healing of acuteCharcot's arthropathy with infrared dermal thermometry.J Rehabil Res Dev 34: 317–321

Armstrong DG, Todd WF, Lavery LA, Harkless LB, Bushman TR (1997) The natural history of acute Charcot's arthropathyin a diabetic foot specialty clinic. Diabet Med 14: 357–363CrossRef

Baumhauer JF, Wervey R, McWilliams J, Harris GF, Shereff MJ (1997) A comparison study of plantar foot pressure in astandardized shoe, total contact cast, and prefabricatedpneumatic walking brace. Foot Ankle Int 18: 26–33PubMedCrossRef

Boninger ML, Leonard JA (1996) Use of bivalved ankle-footorthosis in neuropathic foot and ankle lesions. J RehabilRes Dev 33: 16–22

Boyko EJ, Ahroni JH, Stensel V et al. (1999) A prospectivestudy of risk factors for diabetic foot ulcer. The SeattleDiabetic Foot Study. Diabetes Care 22: 1036–1042CrossRef

Brem H, Sheehan P, Boulton AJ (2004) Protocol for treatmentof diabetic foot ulcers. Am J Surg 187: S1–S10CrossRef

Caputo GM, Ulbrecht J, Cavanagh PR, Juliano P (1998) TheCharcot foot in diabetes: six key points. AmFam Physician57:2705–2710

Cavanagh PR, Boulton AJ, Sheehan P et al. (2002) Therapeuticfootwear in patients with diabetes. JAMA 288: 1231–1233CrossRef

Cavanagh PR, Ulbrecht JS, Caputo GM (1996) Biomechanicalaspects of diabetic foot disease: aetiology, treatment, and prevention. Diabet Med 13 (Suppl 1): S17–S22

Christensen TM, Gade-Rasmussen B, Pedersen LW, Hommel E, Holstein PE, Svendsen OL (2012) Duration of off-loadingand recurrence rate in Charcot osteo-arthropathy treatedwith less restrictive regimen with removable walker. J Diabetes Complications 26(5):430–4

ClohisyDR, Thompson RC (1988) Fractures associated withneuropathic arthropathy in adults who have juvenileonsetdiabetes. J Bone Joint Surg Am 70: 1192–1200

Conti SF (1999) Total contact casting. Instr Course Lect 48:305–315

Dahmen R, Haspels R, Koomen B, Hoeksma AF (2001) Therapeuticfootwear for the neuropathic foot: an algorithm. Diabetes Care 24: 705–709CrossRef

Dargis V, Pantelejeva O, Jonushaite A, Vileikyte L, Boulton AJ (1999) Benefits of a multidisciplinary approach in themanagement of recurrent diabetic foot ulceration inLithuania: a prospective study. Diabetes Care 22:1428–1431CrossRef

Edwards V (1998) A multidisciplinary approach to foot care indiabetes. Community Nurse 4: 53–55

Ghirlanda G, Mancini L, Castagneto M et al. (1997) The footclinic. Multidisciplinary management of the patient withdiabetic foot. Rays 22: 638–643

Gough A, Abraha H, Li F et al. (1997) Measurement of markersof osteoclast and osteoblast activity in patients withacute and chronic diabetic Charcot neuroarthropathy. Diabet Med 14: 527–531CrossRef

Guis S, Pellissier JF, Arniaud D et al. (1999) Healing of Charcot'sjoint by pamidronate infusion. J Rheumatol 26:1843–1845

Hanft JR, Goggin JP, Landsman A, Surprenant M (1998) Therole of combined magnetic field bone growth stimulationas an adjunct in the treatment of neuroarthropathy/Charcot joint: an expanded pilot study. J Foot Ankle Surg 37: 510–515

Henderson VE (1905) Joint affection in tabesdorsalis. J Pathol10: 21–1

Inlow S, Kalla TP, Rahman J (1999) Downloading plantar footpressures in the diabetic patient. Ostomy Wound Manage45: 28-34, 36, 3–8

Jeffcoate WJ, Price P, Harding KG (2004) Wound healing andtreatments for people with diabetic foot ulcers. DiabetesMetab Res Rev 20 (Suppl 1): S78–S89

Jude EB, Selby PL, Burgess J et al. (2001) Bisphosphonates inthe treatment of Charcot neuroarthropathy: a doubleblindrandomised controlled trial. Diabetologia 44:2032–2037CrossRef

Lavery LA, Vela SA, Fleischli JG, Armstrong DG, Lavery DC (1997) Reducing plantar pressure in the neuropathic foot.A comparison of footwear. Diabetes Care 20: 1706–1710CrossRef

McGill M, Molyneaux L, Bolton T et al. (2000) Response ofCharcot's arthropathy to contact casting: assessment byquantitative techniques.iabetologia 43: 481–484

Mehta JA, Brown C, Sargeant N (1998) Charcot restraintorthotic walker. Foot Ankle Int 19: 619–623

Morgan JM, Biehl WC, Wagner FW (1993) Management ofneuropathic arthropathy with the Charcot RestraintOrthotic Walker.ClinOrthop 296: 58–63

Pollo FE, Brodsky JW, Crenshaw SJ, Kirksey C (2003) Plantarpressures in fiberglass total contact casts vs. a newdiabetic walking boot. Foot Ankle Int 24: 45–49

Richard JL, Almasri M, Schuldiner S (2012) Treatment of acuteCharcot foot with bisphosphonates: a systematic reviewof the literature. Diabetologia 55(5):1258–64PubMedCrossRef

Saltzman CL, Johnson KA, Goldstein RH, Donnelly RE (1992) The patellar tendon-bearing brace as treatment forneurotrophicarthropathy: a dynamic force monitoringstudy. Foot Ankle 13: 14–21PubMedCrossRef

Selby PL, Young MJ, Boulton AJ (1994) Bisphosphonates: anew treatment for diabetic Charcot neuroarthropathy?Diabet Med 11: 28–31PubMedCrossRef

Sequeira W (1994) The neuropathic joint. ClinExpRheumatol12: 325–337

Simon SR, Tejwani SG, Wilson DL, Santner TJ, Denniston NL (2000) Arthrodesis as an early alternative to nonoperativemanagement of charcotarthropathy of the diabetic foot[In Process Citation]. J Bone Joint Surg Am 82-A: 939–950

Sinacore DR (1998) Acute Charcot arthropathy in patientswith diabetes mellitus: healing times by foot location.J Diabetes Complications 12: 287–293CrossRef

Sinha S, Munichoodappa CS, Kozak GP (1972) Neuro-arthropathy(Charcot joints) in diabetes mellitus (clinical studyof 101 cases). Medicine 51: 191–210PubMedCrossRef

Sobel E, Levitz SJ, Caselli MA (1999) Orthoses in the treatmentof rearfoot problems. J Am Podiatr Med Assoc 89: 220–233

Stansberry KB, Moss QE, Peppard HR, McNitt PM, Vinik AI (1999) Intravenous bisphosphonate rapidly reverses theparadoxical blood flow to the foot in charcotneuroarthropathy. Diabetes 48 (Suppl. 1): A9–2

Stiendler A (1931) The tabetic arthropathies. JAMA 96: 25–0

Strauss E, Gonya G (1998) Adjunct low intensity ultrasound inCharcot neuroarthropathy. ClinOrthop 349: 132–138

Valk GD, Kriegsman DM, Assendelft WJ (2002) Patient educationfor preventing diabetic foot ulceration.A systematicreview. EndocrinolMetabClin North Am 31: 633–658

Wetz HH (1999) Orthopedic aspects in diabetic neuropathicosteoarthropathy. CurrProblDermatol 27: 242–251

Ahmad J, Pour AE, Raikin SM (2007) The modified use of aproximal humeral locking plate for tibiotalocalcanealarthrodesis. Foot Ankle Int 28(9): 977–83PubMedCrossRef

Aosenbium B et al. (1997) Neuropathic ulceration plantar tothe lateral column in patients with Charcot foot deformity:a flexible approach to limb salvage. J Foot AnkleSurgery 36: 360–363

Assal M, Ray A, Stern R (2010) Realignment and extendedfusion with use of a medial column screw for midfootdeformities secondary to diabetic neuropathy. Surgicaltechnique. J Bone Joint Surg Am 1(92 Suppl. 1):20–31

Brodsky JW (2000) The diabetic foot. In: Mann RA, CoughlinMJ (eds) Surgery of the foot and ankle. Mosby, St. Louis, pp 924–925

Cantanzariti AR, Mendicino R, Haverstock B (2000) Ostectomyfor diabetic neuroarthropathy involving the midfoot.J Foot Ankle Surgery 39:291–300

Caravaggi C, Cimmino M, Caruso S et al. (2006) Intramedullarycompressive nail fixation for the treatment of severeCharcot deformity of the ankle and rear foot. J Foot AnkleSurg 45(1):20–4

Childress HM (1965) Vertical transarticular pin fixation forunstable ankle fractures. J Bone Joint Surg 47A:1323–1334

Dalla Paola L, Brocco, Ceccacci T et al. (2009) Limb salvage inCharcot foot and ankle osteomyelitis: combined usesingle stage/double stage of arthrodesis and externalfixation. Foot Ankle Int 30(11):1065–70PubMedCrossRef

Early JS, Hansen ST (1996) Surgical reconstruction of thediabetic foot: A salvage approach to midfoot collapse. Foot Ankle Int 17: 325–330CrossRef

Faber DC et al. (2002) Single Stage Correction with externalFixation of the ulcerated foot in individuals with CharcotFlynn JM, Rodriguez-del Rio F, Piza PA (2000) Closed anklefractures in the diabetic patient. Foot Ankle Int 21(4): 311–9

Johnson JE et al. (1996) Reconstruction of the Charcot footand ankle: An outcome study of long term results. AmericanOrthopedic Foot and Ankle Society 12th AnnualSummer Meeting, Hilton Head, South Carolina

Johnson JE et al. (1997) Surgical reconstruction of the diabeticCharcot foot and ankle. Foot Ankle Clin 2: 37–55

Koller A et al. (2004) RekonstruktiveFuschirurgiebeidiabetisch-neuropathischerOsteoarthropathie.Orthopade 33:83–991

Laurinaviciene R, Kirketerp-Moeller K, Hollstein PE (2008) Exostectomy for chronic midfoot plantar ulcer in Charcotdeformity.J Wound Care 17:53–58CrossRef

Lowery NJ et al. (2012) Surgical management of Charcotneuroarthropathy of the foot and ankle: A systematicreview. Foot Ankle Int 33: 113–12CrossRef

Mendicino RW et al. (2003) Tibiotalocalcaneal arthrodesiswith retrograde intramedullary nailing. J Foot Ankle Surg43: 82–86

Mihir MJ et al. (2003) A protocol for treatment of unstableankle fractures using transarticular fixation in patientswith diabetes mellitus and loss of protective sensibility. Foot Ankle Int 24: 838–844

Mittelmeier T, Klaue K, Haar P, Beck M (2010): Should oneconsider primary surgical reconstruction in charcotarthropathy of the feet? ClinOrthopRelat Res 468(4):1002–11

Pakarinen TK, Laine HJ, Honkonen SE (2002) Charcot arthropathyof the diabetic foot. Current concepts and reviewof 36 cases. Scand J Surg 91(2):195–201PubMed

Sammarco GJ, Conti SF (1998) Surgical treatment of neuroarthropathicfoot deformity. Foot Ankle Int 19(2):102–9PubMedCrossRef

Sammarco VJ, Sammarco GJ, Walker EW et al. (2009) Midtarsalarthrodesis in the treatment of Charcot midfootarthropathy. Surgical technique. J Bone Joint Surg Am 91(1)80–91PubMedCrossRef

Sanders LJ, Frykberg RG (1991) Diabetic neuropathy osteoarthropathy:The Charcot foot. In: Frykberg RG (ed) Thehigh risk foot in Diabetes mellitus. Churchill Livingstone, New York

Simon SR, Tejwani SG, Wilson DL et al. (2000) Arthrodesis as anearly alternative to nonoperative management of Charcotarthropathy of the diabetic foot. J Bone Joint Surg;226 82A:939–950

Wukich DK, Joseph A, Ryan M et al. (2011) Outcomes of anklefractures in patients with uncomplicated versus complicateddiabetes. Foot Ankle Int 32(2):120–30PubMedCrossRef

Titel: Diagnostik und Therapie bei diabetisch-neuropathischer Osteoarthropathie
verfasst von: Priv.-Doz. Dr. med. S. Zimny
Dr. med. U. Waldecker
Prof. Dr. med. A. Eckardt
Verlag: Springer Berlin Heidelberg
Buch: Der diabetische Fuß
Print ISBN: 978-3-642-38424-0

Electronic ISBN: 978-3-642-38425-7

Copyright-Jahr: 2015
DOI: https://doi.org/10.1007/978-3-642-38425-7_5

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).

Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Neue Osteoporose-Leitlinie: Frakturinzidenz senken, Versorgung verbessern

30.09.2024
DGRh 2024
Kongressbericht

Das sind – zusammen mit dem Erhalt bzw. der Verbesserung der Funktionsfähigkeit und Lebensqualität der Patientinnen und Patienten – die Ziele der 2023er Leitlinie der Osteologischen Fachgesellschaften e.V. (DVO). Noch fremdeln viele Ärztinnen und Ärzte mit den neuen Konzepten und Risikotabellen.

Myositiden – Fortschritte bei der Risikostratifizierung und Diagnostik

30.09.2024
DGRh 2024
Kongressbericht

Bei der Myositis hat sich viel getan, was für den klinischen Alltag relevant ist – so Prof. Dr. Britta Maurer, Universitätsspital Bern, beim Deutschen Rheumatologiekongress 2024. Morbidität und Mortalität könnten zurückgehen.

Mesenchymale Stammzellen praktisch nutzlos gegen Gonarthrose

30.09.2024
Gonarthrose
Nachrichten

Die Idee, mit mesenchymalen Stammzellen arthrotische Kniegelenke zu regenerieren, klingt vielversprechend. Entsprechend zahlreich sind die Angebote dafür. Die Therapie ist allerdings nicht ganz billig – und vermutlich ohne großen Effekt, wie eine Metaanalyse einschlägiger Studien zeigt.

Unterarmfraktur: Tipps für ein zielgerichtetes Vorgehen

29.09.2024
Kongress für Kinder- und Jugendmedizin 2024
Kongressbericht

Bei Verdacht auf eine Unterarmfraktur seien 1000 Entscheidungen in 15 Minuten zu treffen, so der Kinderchirurg Dr. Stephan Rohleder auf dem Kongress für Kinder- und Jugendmedizin. Seine Tipps für ein zielgerichtetes Vorgehen erleichtern die adäquate Versorgung.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Arthropedia, Osteoporotisch bedingte Sinterungsfrakturen der Wirbelsäule/© L. Heuchemer, D. Emmert, T. Bender et al./Springer Medizin Verlag GmbH, Querschnitt diagnostischer Muskelbiopsien bei Myositis/© Schmidt J, Müller-Felber W | all rights reserved Springer Medizin Verlag GmbH, Multipipette mit grüne Flüssigkeit/© luchschenF / stock.adobe.com (Symbolbild mit Fotomodell), Kind mit Gipsarm/© nycshooter / Getty Images / iStock (Symbolbild mit Fotomodell)